Presidency

Paolo A. Ascierto, Director of Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute IRCCS “Fondazione G. Pascale”, Naples, Italy

Bernard A. Fox, Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Institute, Portland, Oregon, US

Rational

After decades of research and clinical trials, vaccines are beginning to impact patient outcomes. While the future is bright, we still have a long way to go.
This event will be an international meeting for experts to share and discuss the latest findings and future perspectives on cancer vaccines.
The objectives of the conference are to:
 
  • Present up-to-date data
  • Interpret clinical and scientific findings and predict potential impact
  • Recognize and characterize the hurdles that remain
  • Provide a vision for the future if hurdles are addressed

 

Per informazioni si prega di inviare una e-mail a eventi@vivenko.net

Segreteria Organizzativa

Informazioni

Scarica il Programma